Show simple item record

dc.contributor.authorMüller, Linda
dc.contributor.authorMester, László
dc.contributor.authorNagy, Anna
dc.contributor.authorHanácsek, Richárd
dc.contributor.authorJanett, Fredi
dc.contributor.authorCseh, Sándor
dc.contributor.authorReichler, Iris Margaret
dc.contributor.authorBalogh, Orsolya
dc.date.accessioned2021-03-29T10:24:55Z
dc.date.available2021-03-29T10:24:55Z
dc.date.issued2018-12
dc.identifier.citationMagyar Állatorvosok Lapja 140(12), 727-736. (2018)en_US
dc.identifier.urihttp://hdl.handle.net/10832/2831
dc.description.abstractSUMMARY Background: Semen characteristics in frequently collected samples after insertion of a Suprelorin® 4.7 mg (Virbac, France) implant have not been reported yet. Objectives: to determine the effects of Suprelorin® 4.7 mg on the quality of semen collected twice weekly, and on metabolic function and health by body weight (BW) changes and serum biochemical (glucose, triglycerides, ALT, AP, BUN, creatinine, total protein, albumin, albumin/globulin ratio, electrolytes) and haematology analysis. Materials and Methods: Five adult healthy male Beagles (31-46 months old, 10.4-13.9 kg) housed together and fed the same ration throughout the study were implanted subcutaneously with 4.7 mg Suprelorin® (d0). Semen was collected twice weekly. DNA fragmentation index (% DFI) was determined with Sperm Chromatin Structure Assay (SCSATM). BW measurements and blood sampling were performed on d0, d21, and biweekly until d112. Data was analysed with general linear model with repeated measures. Results and Discussion: BW was stable and haematology and biochemical parameters remained in the normal range. In 4 dogs semen could be collected until d10 and until d17 in the last dog. No changes in ejaculate volume, sperm concentration, total number of spermatozoa, progressive motility, morphology and % DFI (1.33-4.50% frozen-thawed 0 h, 1.49-6.66% frozen-thawed after 3 h incubation at 38 °C) were detected (P≥0.112).. As semen quality was not significantly influenced, matings may result in viable offspring until aspermia occurs. Under controlled feeding conditions, 4.7 mg Suprelorin® administration does not result in BW changes and in any alterations of blood parameters.en_US
dc.language.isohuen_US
dc.publisherMagyar Állatorvosok Lapjaen_US
dc.titleDeslorelin tartalmú implantátummal (Suprelorin® 4,7 mg) végzett kémiai kasztráció hatása a spermaminőségre, a testtömegre, a vér egyes biokémiai paramétereire és a vérképre ivarérett Beagle kan kutyákban - Irodalmi összefoglaló és saját tapasztalatoken_US
dc.title.alternativeEffect of a long-acting deslorelin implant (Suprelorin® 4.7 mg) on semen characteristics, body weight, serum biochemical and haematology profile in adult male Beagle dogs - Literature review and a prospective studyen_US
dc.typeArticleen_US
dcterms.bibliographicCitationMagyar Állatorvosok Lapja 140(12), 727-736. (2018)


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record